Next Article in Journal
A Case of Thrombotic Thrombocytopenic Purpura without Pathognomonic Schistocytes
Previous Article in Journal
Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Inappropriate Sinus Tachycardia Following Viral Illness

1
Internal Medicine Division, White River Health System, Batesville, AR 72501, USA
2
Cardiology Division, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
3
Electrophysiology Division, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
*
Author to whom correspondence should be addressed.
Clin. Pract. 2021, 11(2), 219-222; https://doi.org/10.3390/clinpract11020032
Submission received: 17 March 2021 / Revised: 26 March 2021 / Accepted: 6 April 2021 / Published: 9 April 2021

Abstract

:
A 67-year-old female patient with a past medical history of menopause, migraines, and gastro-esophageal disease presented with palpitation, fatigue, and shortness of breath. One month prior to her presentation, she reported having flu-like symptoms. Her EKG showed sinus tachycardia with no other abnormality. Laboratory findings, along with imaging, showed normal results. The event monitor failed to detect any arrythmias. We report a case of inappropriate sinus tachycardia secondary to viral infection as a diagnosis of exclusion.

1. Introduction

Inappropriate sinus tachycardia, also called chronic non-paroxysmal sinus tachycardia, is an unusual condition that occurs in individuals without apparent heart disease or other cause of sinus tachycardia, such as hyperthyroidism or fever, and is generally considered a diagnosis of exclusion [1,2,3,4]. Inappropriate sinus tachycardia is defined as a resting heart rate >100 beats per minute associated with highly symptomatic palpitations [5,6].
Commonly used criteria to define inappropriate sinus tachycardia include [7] P-wave axis and morphology similar to sinus rhythm, and a resting heart rate of 100 beats per minute or greater (with a mean heart rate >90 beats per minute over 24 h). Additionally, patients with inappropriate sinus tachycardia classically experience a drop in heart rate during sleep, as well as palpitations, presyncope, or both, related to the tachycardia. Very rarely do patients experience syncope. Exclusion of identifiable causes of sinus tachycardia is the method of diagnosis.

2. Case Presentation

A 67-year-old female patient with a past medical history of menopause, migraines, and gastro-esophageal disease presented with palpitation, fatigue, and shortness of breath. One month prior to her presentation, she reported having flu-like symptoms. Her home medications include estradiol 0.025 mg weekly, glucosamine/chondroitin 500–400 mg twice daily, omeprazole 50 mg once daily, and zolmitriptan 5 mg as needed. Physical examination was normal.
Laboratory results were as follows: WBC 8.64 K/uL (3.60–9.50), creatinine 0.8 mg/dL (0.4–1.0), TSH 1.69 uIU/mL (0.34–5.60), troponin < 0.03 ng/mL (≤0.4), D-dimer 387 ng/mL (<670), BNP < 10 pg/mL (≤106), CRP < 5.00 mg/L (≤10.00), procalcitonin 0.04 ng/mL (0.00–0.10); urine analysis negative; COVID-19 PCR infection negative; chest X-ray with no acute findings; echocardiograph with grade I diastolic dysfunction; and EF 60–65% (Figure 1 and Figure 2). EKG showed sinus tachycardia with a heart rate of 101 bpm (Figure 3). Lung CTA was observed with no significant lung pathology, and the pulmonary function test was within normal limits.
The patient started on metoprolol succinate 25 mg daily and was set up with an event monitor for a two-week duration to rule out any arrythmias. She was advised to practice relaxation exercises, such as yoga and tai chi. At the one month follow-up, the event monitor showed no arrhythmias. Only one episode of asymptomatic premature ventricular complex was detected. The patient reported improvement with her symptoms, and, thus, she was diagnosed with inappropriate sinus tachycardia, as part of her previous viral illness, by exclusion.

3. Discussion

Most patients with inappropriate sinus tachycardia are young and female. Among a single-center cohort of 305 patients with inappropriate sinus tachycardia seen between 1998 and 2018, 92% were female, with an average age of 33 years [8]. Affected patients have an elevated resting heart rate and/or an exaggerated heart rate response to exercise that is out of proportion to their body’s physiological needs; many patients have both.
Patients are invariably symptomatic; the presence of symptoms is an essential component of the definition. In contrast to sinus tachycardia occurring as a physiologic response, inappropriate sinus tachycardia can continue for months or years and may produce troublesome symptoms, most commonly palpitations. However, other common symptoms include chest discomfort, fatigue, dizziness, presyncope, syncope, and shortness of breath [8]. Most patients have resting heart rates of greater than 100 beats per minute and average heart rates on a 24 h Holter greater than 90 beats per minute, with no clear physiologic, pathologic, or pharmacologic trigger [4].
The pathophysiologic mechanism behind this disease is poorly understood and is thought to consist of intrinsic sinus node hyperactivity coupled with autonomic perturbations modulated by neurohormonal influences [4]. One study suggested that this tachycardia is related to a primary sinus node abnormality characterized by a high intrinsic heart rate, depressed efferent cardiovagal reflex, and beta-adrenergic hypersensitivity [2,4].
Inappropriate sinus tachycardia is an unusual condition of unknown etiology that occurs in individuals without apparent heart disease or other cause of sinus tachycardia. Before embarking on treatment, exclusion of secondary causes of sinus tachycardia is imperative, as it is a normal physiologic response to exercise and conditions in which catecholamine release is physiologically enhanced or, less commonly, in situations where the parasympathetic nervous system is withdrawn. Among the most common causes are anxiety and pain. Patients with such presentation will often require simple reassurance with return of the sinus rate to the normal range [9].
Treatment of symptomatic inappropriate sinus tachycardia is challenging, often with suboptimal results. For patients with symptomatic inappropriate sinus tachycardia, a trial of beta blockade as the initial medical therapy with a daily dose of 25 to 50 mg long-acting metoprolol, with upward titration for adequate heart rate and symptom control classified as 2C, is suggested. For patients with persistently symptomatic inappropriate sinus tachycardia, using ivabradine (5 to 7.5 mg twice daily) as well as a class 2C classification, is suggested. For patients with persistent symptomatic inappropriate sinus tachycardia despite optimal pharmacologic therapy, radiofrequency catheter ablation may be attempted. However, postural orthostatic tachycardia syndrome must be excluded first since ablation may worsen symptoms in these patients.

4. Conclusions

Inappropriate sinus tachycardia is a diagnosis of exclusion after ruling out causes of sinus tachycardia. It can be seen as a physiological response after a viral illness, as seen in this case. Treatment is often challenging and with suboptimal results. However, long-acting b-blockers are recommended as initial medical therapy.

Author Contributions

K.S.—Writing and gathering date for the manuscript; F.H., S.V. and H.P.—Reviewing the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This manuscript received no funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Verbal Consent was obtained directly from the patient to publish this manuscript.

Data Availability Statement

Data available upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bauernfeind, R.A.; Amat-Y-Leon, F.; Dhingra, R.C.; Kehoe, R.; Wyndham, C.; Rosen, K.M. Chronic Nonparoxysmal Sinus Tachycardia in Otherwise Healthy Persons. Ann. Intern. Med. 1979, 91, 702. [Google Scholar] [CrossRef] [PubMed]
  2. Morillo, C.A.; Klein, G.J.; Thakur, R.K.; Li, H.; Zardini, M.; Yee, R. Mechanism of ’inappropriate’ sinus tachycardia. Role of sympathovagal balance. Circulation 1994, 90, 873–877. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Krahn, A.D.; Yee, R.; Klein, G.J.; Morillo, C. Inappropriate Sinus Tachycardia: Evaluation and Therapy. J. Cardiovasc. Electrophysiol. 1995, 6, 1124–1128. [Google Scholar] [CrossRef] [PubMed]
  4. Olshansky, B.; Sullivan, R.M. Inappropriate Sinus Tachycardia. J. Am. Coll. Cardiol. 2013, 61, 793–801. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Sheldon, R.S.; Grubb, B.P.; Olshansky, B.; Shen, W.-K.; Calkins, H.; Brignole, M.; Raj, S.R.; Krahn, A.D.; Morillo, C.A.; Stewart, J.M.; et al. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Hear. Rhythm. 2015, 12, e41–e63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Page, R.L.; Joglar, J.A.; Caldwell, M.A.; Calkins, H.; Conti, J.B.; Deal, B.J.; Estes, N.M.; Field, M.E.; Goldberger, Z.D.; Hammill, S.C.; et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients with Supraventricular Tachycardia. Circulation 2016, 133, e506–e574. [Google Scholar] [CrossRef] [PubMed]
  7. Lee, R.J.; Shinbane, J.S. Inappropriate Sinus Tachycardia. Cardiol. Clin. 1997, 15, 599–605. [Google Scholar] [CrossRef]
  8. Shabtaie, S.A.; Witt, C.M.; Asirvatham, S.J. Natural history and clinical outcomes of inappropriate sinus tachycardia. J. Cardiovasc. Electrophysiol. 2019, 31, 137–143. [Google Scholar] [CrossRef] [PubMed]
  9. Severino, P.; Mariani, M.V.; Maraone, A.; Piro, A.; Ceccacci, A.; Tarsitani, L.; Maestrini, V.; Mancone, M.; LaValle, C.; Pasquini, M.; et al. Triggers for Atrial Fibrillation: The Role of Anxiety. Cardiol. Res. Pract. 2019, 2019, 1–5. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Echocardiography showing four-chamber view with no valvular or structural abnormalities.
Figure 1. Echocardiography showing four-chamber view with no valvular or structural abnormalities.
Clinpract 11 00032 g001
Figure 2. Echocardiography showing mitral valve and left ventricle with no pericardial effusion.
Figure 2. Echocardiography showing mitral valve and left ventricle with no pericardial effusion.
Clinpract 11 00032 g002
Figure 3. EKG showing sinus tachycardia with heart rate of 101 bpm.
Figure 3. EKG showing sinus tachycardia with heart rate of 101 bpm.
Clinpract 11 00032 g003
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sawalha, K.; Habash, F.; Vallurupalli, S.; Paydak, H. Inappropriate Sinus Tachycardia Following Viral Illness. Clin. Pract. 2021, 11, 219-222. https://doi.org/10.3390/clinpract11020032

AMA Style

Sawalha K, Habash F, Vallurupalli S, Paydak H. Inappropriate Sinus Tachycardia Following Viral Illness. Clinics and Practice. 2021; 11(2):219-222. https://doi.org/10.3390/clinpract11020032

Chicago/Turabian Style

Sawalha, Khalid, Fuad Habash, Srikanth Vallurupalli, and Hakan Paydak. 2021. "Inappropriate Sinus Tachycardia Following Viral Illness" Clinics and Practice 11, no. 2: 219-222. https://doi.org/10.3390/clinpract11020032

APA Style

Sawalha, K., Habash, F., Vallurupalli, S., & Paydak, H. (2021). Inappropriate Sinus Tachycardia Following Viral Illness. Clinics and Practice, 11(2), 219-222. https://doi.org/10.3390/clinpract11020032

Article Metrics

Back to TopTop